|
|
Gene Symbol |
PDGFRA |
|
Aliases |
CD140A, PDGFR-2, PDGFR2 |
|
Entrez Gene ID |
|
|
Gene Name |
Platelet derived growth factor receptor alpha |
|
Chromosomal Location |
4q12 |
|
HGNC ID |
|
|
Summary |
This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0001775 |
Biological process |
Cell activation |
TAS |
10508235 |
GO:0002244 |
Biological process |
Hematopoietic progenitor cell differentiation |
IBA |
21873635 |
GO:0007169 |
Biological process |
Transmembrane receptor protein tyrosine kinase signaling pathway |
IBA |
21873635 |
GO:0007204 |
Biological process |
Positive regulation of cytosolic calcium ion concentration |
IMP |
2554309 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IBA |
21873635 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IDA |
10806482 |
GO:0008284 |
Biological process |
Positive regulation of cell proliferation |
IMP |
2554309 |
GO:0010544 |
Biological process |
Negative regulation of platelet activation |
IDA |
8188664 |
GO:0010863 |
Biological process |
Positive regulation of phospholipase C activity |
IMP |
1646396 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
TAS |
10734113 |
GO:0018108 |
Biological process |
Peptidyl-tyrosine phosphorylation |
IDA |
1646396, 2536956, 8188664 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IDA |
17470632 |
GO:0030335 |
Biological process |
Positive regulation of cell migration |
IMP |
1646396 |
GO:0034614 |
Biological process |
Cellular response to reactive oxygen species |
IDA |
24190966 |
GO:0035790 |
Biological process |
Platelet-derived growth factor receptor-alpha signaling pathway |
IMP |
2554309 |
GO:0038091 |
Biological process |
Positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
IDA |
17470632 |
GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IBA |
21873635 |
GO:0043552 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase activity |
IMP |
1646396 |
GO:0046777 |
Biological process |
Protein autophosphorylation |
IDA |
1646396, 2536956, 8188664 |
GO:0048008 |
Biological process |
Platelet-derived growth factor receptor signaling pathway |
IDA |
2536956, 10806482 |
GO:0048015 |
Biological process |
Phosphatidylinositol-mediated signaling |
IMP |
2554309 |
GO:0048146 |
Biological process |
Positive regulation of fibroblast proliferation |
IDA |
10806482 |
GO:0050920 |
Biological process |
Regulation of chemotaxis |
IMP |
2554309 |
GO:0060326 |
Biological process |
Cell chemotaxis |
IMP |
1646396 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IBA |
21873635 |
GO:0070374 |
Biological process |
Positive regulation of ERK1 and ERK2 cascade |
IMP |
10734113 |
GO:0070527 |
Biological process |
Platelet aggregation |
IMP |
8188664 |
GO:2000249 |
Biological process |
Regulation of actin cytoskeleton reorganization |
TAS |
10734113 |
GO:2000739 |
Biological process |
Regulation of mesenchymal stem cell differentiation |
IMP |
21596750 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IBA |
21873635 |
GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IDA |
2536956 |
GO:0016020 |
Cellular component |
Membrane |
HDA |
19946888 |
GO:0031226 |
Cellular component |
Intrinsic component of plasma membrane |
IDA |
2554309 |
GO:0032991 |
Cellular component |
Protein-containing complex |
IDA |
24190966 |
GO:0043235 |
Cellular component |
Receptor complex |
IBA |
21873635 |
GO:0004672 |
Molecular function |
Protein kinase activity |
IDA |
24190966 |
GO:0004714 |
Molecular function |
Transmembrane receptor protein tyrosine kinase activity |
IBA |
21873635 |
GO:0004714 |
Molecular function |
Transmembrane receptor protein tyrosine kinase activity |
IDA |
1646396 |
GO:0005018 |
Molecular function |
Platelet-derived growth factor alpha-receptor activity |
IBA |
21873635 |
GO:0005018 |
Molecular function |
Platelet-derived growth factor alpha-receptor activity |
IDA |
2536956, 8188664, 10806482 |
GO:0005018 |
Molecular function |
Platelet-derived growth factor alpha-receptor activity |
IMP |
2554309 |
GO:0005021 |
Molecular function |
Vascular endothelial growth factor-activated receptor activity |
IDA |
17470632 |
GO:0005161 |
Molecular function |
Platelet-derived growth factor receptor binding |
IPI |
2542288 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
7679113, 9546424, 10733900, 10806482, 17470632, 24658140, 25241761, 25416956 |
GO:0038085 |
Molecular function |
Vascular endothelial growth factor binding |
IPI |
17470632 |
GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
2542288 |
GO:0048407 |
Molecular function |
Platelet-derived growth factor binding |
IBA |
21873635 |
GO:0048407 |
Molecular function |
Platelet-derived growth factor binding |
IDA |
2554309, 8188664 |
GO:0048407 |
Molecular function |
Platelet-derived growth factor binding |
IPI |
2536956, 10806482 |
|
Protein Information |
|
Protein Name |
Platelet-derived growth factor receptor alpha, CD140 antigen-like family member A, CD140a antigen, PDGF-R-alpha, alpha-type platelet-derived growth factor receptor, platelet-derived growth factor receptor 2, platelet-derived growth factor receptor, alpha polypeptide |
|
Function |
Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000354720 |
Q9UQE7 |
Q9UQE7 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Hypereosinophilic syndrome |
|
Anemia |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Cleft palate |
|
Status Dysraphicus |
|
Congenital abnormality of respiratory system |
|
Fetal Alcohol Syndrome |
|
Endocrine System Diseases |
PCOS |
|
Eye Diseases |
Astigmatism |
|
Neoplasms |
Gastrointestinal Cancer |
12949711, 15146165, 14645423, 17087936, 12522257, 17566086, 22718859, 16954519, 22745105, 18794084, 26130666, 16638875, 15928335, 25157968, 15685537, 17087943, 20028860 |
Chondrosarcoma |
|
Sarcoma |
|
Medulloblastoma |
|
Leukemia |
|
Cancer Metastasis |
|
Nervous System Diseases |
Spina Bifida |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
Xu Huiyu, Han Yong, Lou Jiaying, Zhang Hongxian, Zhao Yue, Gyorffy Balazs, Li Rong |
Department of Obstetrics and Gynecology, Reproductive Medical Center, Peking University Third Hospital, Beijing, P.R. China.| Department of Pathology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang Province, P.R. China.| Department of Clinical Laboratory, Renmin Hospital of Xiaoshan District, Hangzhou, Zhejiang Province, P.R. China.| Department of Urology, Peking University Third Hospital, Beijing, P.R. China.| Department of Obstetrics and Gynecology, Reproductive Medical Center, Peking University Third Hospital, Beijing, P.R. China.| Momentum Cancer Biomarker Research Group, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.| Second Department of Pediatrics, Semmelweis University, Budapest, Hungary.| Department of Obstetrics and Gynecology, Reproductive Medical Center, Peking University Third Hospital, Beijing, P.R. China. |
Oncotarget. 2017 May 13;8(41):69520-69526. doi: 10.18632/oncotarget.17846. |
Abstract
To explore the key genes associated with both PCOS and breast cancer, we overlapped the synchronously differently expressed genes in two obese insulin-resistant GEO datasets in muscle tissue and genes exert essential roles in breast cancer prognosis together base on the following reasons: (1) Androgens excess is believed to contribute to the onset of both PCOS and breast cancer. (2) PCOS is usually complicated with metabolic symptoms, such as obesity and insulin-resistance. (3) Muscle is the main place where energy metabolism and material metabolism take place. Consequently, 53 genes were found, functionally enriched in pathways such as pyruvate metabolism, muscle system process and development of primary male sexual characteristics etc. We further lay our eyes on genes correlated with male sexual characteristics, which may be involved in the onset of both PCOS and breast cancer. Three genes were indicated to be associated with this process, including hydroxysteroid (17-beta) dehydrogenase 4/HSD17B4, platelet-derived growth factor receptor, alpha polypeptide/PDGFRA and high-mobility group box 2/HMGB2. Gene-drug interaction network about the three genes were then constructed. Drugs or chemicals that contribute to correcting the disorder of lipid metabolism were detected to restore the abnormal expression of the three genes in PCOS, such as simvastatin, bezafibrate, fenofibrate et al, which provide further choices for managing patients with PCOS. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|